National Sickle Cell and Thalassemia Blood Group Genotyping Programme

NHS England · Awarded

Buyer
NHS England
Status
Awarded
Country
United Kingdom
Region
England
Sector
Professional Services
Reference
FaT-ocds-h6vhtk-04040b
Published
2023-09-26
Deadline
2026-04-19

Tender summary

12-month programme will enable genotyping of blood groups by NHS BT in current patients (up to 17,800 patients) with either sickle cell or thalassemia.

This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.

Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.

Register for full access

IT tenders · Construction tenders · Sitemap